en
Scientific article
English

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

Published inBreast Cancer Research and Treatment, vol. 174, no. 3, p. 775-783
Publication date2019
Abstract

BRCA1 and BRCA2 proteins are central to DNA repair process through homologous recombination. We hypothesize that BRCA1/BRCA2 mutation carriers may exhibit increased hematological toxicity when receiving genotoxic chemotherapy.

Citation (ISO format)
FRIEDLAENDER, Alex et al. BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. In: Breast Cancer Research and Treatment, 2019, vol. 174, n° 3, p. 775–783. doi: 10.1007/s10549-018-05127-2
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0167-6806
312views
3downloads

Technical informations

Creation04/04/2019 2:25:00 PM
First validation04/04/2019 2:25:00 PM
Update time03/15/2023 5:42:39 PM
Status update03/15/2023 5:42:38 PM
Last indexation10/19/2023 10:42:58 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack